0 Комментарии
0 Поделились
537 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Marketplace
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Why Are Diagnostic Advancements Accelerating the Hematology Analysers Market?Executive Summary Hematology (CBC) Analysers Market Market Size and Share Across Top Segments CAGR Value The global hematology (CBC) analysers market was valued at USD 5.76 billion in 2024 and is expected to reach USD 8.01 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 4.20%, primarily driven by the increased demand for accurate and...0 Комментарии 0 Поделились 426 Просмотры 0 предпросмотр
-
GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...0 Комментарии 0 Поделились 370 Просмотры 0 предпросмотр
-
Is the Global EPO Drugs Market Expanding With Rising Chronic Kidney Disease and Anemia Cases?Executive Summary Erythropoietin (EPO) Drugs Market Size and Share Forecast The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period The Erythropoietin (EPO) Drugs report also makes available CAGR value fluctuation...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...0 Комментарии 0 Поделились 101 Просмотры 0 предпросмотр
-
Why Is the Global Bone Marrow Biopsy Market Growing With Rising Blood Disorder Diagnostics?Future of Executive Summary Bone Marrow Biopsy Market: Size and Share Dynamics Data Bridge Market Research analyses a significant growth in the global bone marrow biopsy market in the forecast period 2022-2029. The expected CAGR of global bone marrow biopsy market is tend to be around 6.3% in the mentioned forecast period. The Bone Marrow Biopsy report encompasses the key developments in...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Will EPO Drugs Continue to Revolutionize Anemia Treatment?Global Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period Global Erythropoietin (EPO) Drugs Market report is a...0 Комментарии 0 Поделились 561 Просмотры 0 предпросмотр
Спонсоры
Спонсоры